Instead, some have suggested that high TIMP-2 levels may promote tumourigenecity [24, 64, 65], which has been strengthened by the association of high TIMP-2 levels with poor prognosis in various human cancers, including breast [66–71]. This evidence concerns the gene TIMP2 and cancer.